4.5 Review

Ultrasonic-Activated Micellar Drug Delivery for Cancer Treatment

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 98, Issue 3, Pages 795-811

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21444

Keywords

micelle; ultrasound; drug delivery; chemotherapy; cancer; surfactant; controlled release/delivery

Funding

  1. National Institutes of Health [CA 98138]
  2. NATIONAL CANCER INSTITUTE [R01CA098138] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The use of nanoparticles and ultrasound in medicine continues to evolve. Great strides have been made in the areas of producing micelles, nanoemulsions, and solid nanoparticles that can be used in drug delivery. An effective nanocarrier allows for the delivery of a high concentration of potent medications to targeted tissue while minimizing the side effect of the agent to the rest of the body. Polymeric micelles have been shown to encapsulate therapeutic agents and maintain their structural integrity at lower concentrations. Ultrasound is currently being used in drug delivery as well as diagnostics, and has many advantages that elevate its importance in drug delivery. The technique is noninvasive, thus no surgery is needed; the ultrasonic waves can be easily controlled by advanced electronic technology so that they can be focused oil the desired target volume. Additionally, the physics of ultrasound are widely used and well understood; thus ultrasonic application can be tailored towards a particular drug delivery system. In this article, we review the recent progress made in research that utilizes both polymeric micelles and ultrasonic power in drug delivery. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:795-811, 2009

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available